Moreover, we have previously shown that IL23/IL17 transcript levels correlate well to the grade of inflammation in IBD [2] and treatment with anti-TNF to complete endoscopic remission has shown to effectively reduce these cytokines in CD [25] and in UC [22]. This evidence concerns the gene TNF and inflammatory bowel disease.